MATTER announces cohort for Restoring Brain Health Innovation Challenge, supported by Lundbeck US Charitable Fund

Five data science startups selected to participate in accelerator

October 31, 2023, CHICAGO — MATTER, the premier healthcare incubator and innovation hub, with support from the Lundbeck US Charitable Fund, a corporate foundation dedicated to responsibly giving back to the community, has selected five startups to participate in the Restoring Brain Health Innovation Challenge.

The 10-week, cohort-based accelerator will provide startups with mentorship, exclusive resources and an interactive curriculum to help them build their solutions and accelerate their growth. They will also have the opportunity to pitch their solutions to key stakeholders from the healthcare ecosystem at a final showcase on January 30, 2024. Each participant will graduate from the program with actionable next steps to further advance their solutions over the subsequent six months with a free MATTER membership.

Learn more about the startups

1step logo 1step — Bolingbrook, Illinois
1step aims to facilitate the centralization of the extensive repository of open-source data on patients with Alzheimer’s disease while ensuring data comparability. These insights hold the promise of enabling clinicians to intervene proactively, potentially enhancing the quality of life for affected individuals. Moreover, this valuable resource will be made accessible for research endeavors, advancing the ongoing battle against Alzheimer’s disease.

Cognes Medical Solutions logo Cognes Medical Solutions — Helsingborg, Sweden
Cognes Medical Solutions is a med tech company specializing in early dementia detection through a cutting-edge SaaS solution. Utilizing machine learning and computer vision technologies, they analyze facial features for digital biomarkers indicative of early signs of dementia. Focused on scalability and accuracy, their platform aims to revolutionize the way the healthcare industry, academic institutions and insurance companies approach dementia screening and treatment.

Ellison Laboratories logo Ellison Laboratories — Wellington, Florida
Ellison Laboratories improves outcomes for a diverse aging population by providing transparency into healthcare data across care settings and assembling a longitudinal patient record. This helps patients and caregivers manage care and helps providers have the requisite information to devise proper diagnoses and treatment plans. The data is then leveraged to provide user-friendly health summaries and chronic disease risk predictions including risk predictions for Alzheimer’s and related diseases.

Neurowyzr logo Neurowyzr — Singapore
Neurowyzr is a deep neuroscience and brain capital company using the latest discoveries in neuroscience to optimize corporate and population brain health and performance. Built by neuroscientists and powered by advanced analytics and AI, Neurowyzr offers a digital platform and software as a service to unlock the potential of individuals and organizations.

SMARTCharts logo SMARTCharts — Chicago, Illinois
SMARTCharts is a web-based application that automates clinician documentation and facilitates communications via visualization in speech, occupational and physical therapy.


At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 800 current and alumni startups from around the world, working together with dozens of hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives. For more information, visit and follow @MATTERhealth.

About Lundbeck US Charitable Fund

The Lundbeck US Charitable Fund is an independently managed nonprofit 501(c)(3) committed to responsibly and appropriately supporting organizations and programs that share our dedication to restoring brain health. The Lundbeck US Charitable Fund is wholly owned by H. Lundbeck A/S, a global pharmaceutical company specialized in brain diseases. For more than 70 years, Lundbeck has been at the forefront of neuroscience research, tirelessly dedicated to restoring brain health so every person can be their best.